...
【24h】

GCLE's Bright Prospect

机译:GCLE的光明前景

获取原文
获取原文并翻译 | 示例
           

摘要

GCLE(7-phenylacetamide-3-chloromethyl-3-cepharn-4-carboxylic acid p-methoxybenzyl ester)as an important intermediate of cephalosporin antibiotics is not new in China.GCLE,7-ADCA(7-aminodeacetoxyl)and 7-ACA(7-aminocephalosporanic acid)are called three major cephalosporin antibiotic intermediates.Comparatively speaking,the start of the GCLE production was not as early as 7-ADCA and 7-ACA and the production scale was also not that large.The main reason was either that CGLE downstream cephalosporin drugs were still in the patent protection period or that the use of earlier and more matured intermediates restricted the application dissemination of GCLE.
机译:GCLE(7-苯基乙酰胺-3-氯甲基-3-cepharn-4-羧酸对甲氧基苄酯)作为头孢菌素抗生素的重要中间体在中国并不新鲜。GCLE,7-ADCA(7-氨基脱乙酰氧基)和7-ACA (7-aminocephalosporanicic acid)被称为三种主要的头孢菌素抗生素中间体。相对而言,GCLE的生产开始不及7-ADCA和7-ACA早,而且生产规模也没有那么大。 CGLE下游头孢菌素药物仍处于专利保护期,或者使用更早和更成熟的中间体限制了GCLE的应用传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号